Hayden is an associate editor for The American Journal of Managed Care® (AJMC®). She joined the AJMC team in 2021, where she produces written and video content covering multiple disease states.
She has a BA in journalism & media studies from Rutgers University. You can connect with Hayden on LinkedIn.
Experts Call for Health System Action to Reduce Hypoglycemia Risk in Older Adults With Diabetes
August 10th 2023According to one panelist, the leading causes of hypoglycemia in older adults are insufficient nutrition and taking the wrong dose or type of insulin, both of which can be addressed at the patient and system level.
Exercise May Reduce Chemotherapy-Induced Peripheral Neuropathy Symptoms in Women With Ovarian Cancer
August 9th 2023While there is currently no effective treatment for chemotherapy-induced peripheral neuropathy, one of the most common and severe adverse effects for patients who have undergone chemotherapy for ovarian cancer, a 6-month aerobic exercise intervention significantly improved symptoms.
Certain Fertility Treatments Do Not Increase CVD Risk for Mothers, Study Says
August 9th 2023New research shows that in vitro fertilization with or without intracytoplasmic sperm injection and the use of fresh or frozen embryo transfers were not associated with an increased risk of cardiovascular disease (CVD) for the mother.
Niraparib Maintenance Therapy Improves PFS by 55% in Advanced Ovarian Cancer
August 2nd 2023Results of the phase 3 PRIME study showed that treatment with niraparib with an individualized starting dose significantly extended progression-free survival (PFS) and reduced the risk of disease progression or death by 55% compared with placebo.
Dr Ghassan Abou-Alfa Expands on HIMALAYA Phase 3 Results, Methods
July 29th 2023Ghassan Abou-Alfa, MD, medical oncologist at Memorial Sloan Kettering Cancer Center, expands on findings that durvalumab plus tremelimumab demonstrated an overall survival benefit at 4 years for certain patients with unresectable hepatocellular carcinoma.
SGLT2is Reduce Recurrent Gout Flare More Than DPP-4is in Patients With Diabetes, Study Says
July 27th 2023Initiation of sodium-glucose cotransporter-2 inhibitors (SGLT2is) was associated with a 34% lower rate of recurrent gout flare compared with initiation of dipeptidyl peptidase 4 inhibitors (DPP-4is).
Cell Protein GRP78 Affects Cancer Cell Spread, USC Study Reveals
July 25th 2023New research suggests that when cancer cells are under stress, cellular chaperone protein GRP78 alters its behavior and migrates to the cell's nucleus, where it modifies gene activities and allows cancer cells to become more mobile and invasive.
Concentrated Exercise Reduces Cardiovascular Risk Similarly to Distributed Exercise
July 18th 2023Research suggests that intense physical activity concentrated within 1-2 days and activity more evenly distributed activity across several days are associated with similarly lower risk of cardiovascular outcomes.
Texas Oncology's Sydney Townsend Spotlights Mental Health in Cancer Care Journey
July 14th 2023Sydney Townsend, executive director of digital health at Texas Oncology, explains how cancer diagnosis and treatment can impact a patient’s mental well-being and how she assesses a patient’s overall cancer care experience.